Consolidated Balance Sheets - The revision relating to currency translation discussed above had no impact on total stockholders’ equity, but impacted the components of stockholders’ equity as follows (in thousands):



	As of December 31, 2018
	As previously reported			Revisions			As revised
Accumulated other comprehensive loss	$	(1,116	)	$	1,147		$	31
Retained earnings (accumulated deficit)	(107,176		)	(1,147		)	(108,323		)



	As of March 31, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(1,022	)	$	1,147		$	125
Retained earnings (accumulated deficit)	(76,314		)	(1,147		)	(77,461		)



	As of June 30, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(998	)	$	1,147		$	149
Retained earnings (accumulated deficit)	(90,727		)	(1,147		)	(91,874		)



	As of September 30, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(962	)	$	1,147		$	185
Retained earnings (accumulated deficit)	(101,770		)	(1,147		)	(102,917		)



	As of December 31, 2019
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(966	)	$	1,147		$	181
Retained earnings (accumulated deficit)	(141,091		)	(1,147		)	(142,238		)



	As of March 31, 2020
	As previously reported*			Revisions			As revised
Accumulated other comprehensive loss	$	(1,089	)	$	1,147		$	58
Retained earnings (accumulated deficit)	(205,058		)	(1,147		)	(206,205		)

*As previously reported numbers reflect the revised balances for each of the periods as disclosed in the period ended March 31, 2020.

Consolidated Statements of Cash Flows - The revision discussed above impacted the statement of cash flow as follows (in thousands):



	For the three months ended March 31, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(18,661	)	$	14,219		$	(4,442	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(25,721		)	17,505			(8,216		)
Proceeds from sale of business	169,722			(17,505		)	152,217
Net cash provided by investing activities	169,290			(17,505		)	151,785



	For the six months ended June 30, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(16,209	)	$	14,219		$	(1,990	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(23,849		)	17,505			(6,344		)
Proceeds from sale of business	169,722			(17,505		)	152,217
Net cash provided by investing activities	168,868			(17,505		)	151,363



	For the nine months ended September 30, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(14,974	)	$	10,938		$	(4,036	)
Other long-term assets	—			3,286			3,286
Net cash used in operating activities	(14,348		)	14,224			(124		)
Proceeds from sale of business	169,722			(14,224		)	155,498
Net cash provided by investing activities	167,497			(14,224		)	153,273



	For the year ended December 31, 2019
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	(8,359	)	$	10,938		$	2,579
Other long-term assets	1,131			3,286			4,417
Net cash used in operating activities	(18,769		)	14,224			(4,545		)
Proceeds from sale of business	169,722			(14,224		)	155,498
Net cash provided by investing activities	166,937			(14,224		)	152,713



	For the three months ended March 31, 2020
	As previously reported			Revisions			As revised
Adjustment to reconcile net cash in operating activities
Other current assets	$	6,926		$	(3,281	)	$	3,645
Net cash used in operating activities	(20,496		)	(3,281		)	(23,777		)
Proceeds from sale of business	—			3,281			3,281
Net cash provided by investing activities	41			3,281			3,322